Keros Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Keros Therapeutics, Inc. (KROS) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2024-02-28
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-12-31 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-09-30 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-06-30 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-03-31 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was $0.00.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$62.00K.
- Keros Therapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2020 was -$57.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | -$16.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | -$16.00K derived: sum of 3 quarters · filed 2024-02-28 | -$32.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 | -$16.00K derived: sum of 2 quarters · filed 2024-02-28 | -$32.00K derived: sum of 3 quarters · filed 2024-02-28 | -$47.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$32.00K derived: sum of 2 quarters · filed 2024-02-28 | -$47.00K derived: sum of 3 quarters · filed 2024-02-28 | -$62.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$31.00K derived: sum of 2 quarters · filed 2022-11-03 | -$46.00K 10-Q · filed 2022-11-03 | -$61.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$30.00K 10-Q · filed 2022-08-04 | -$45.00K derived: sum of 3 quarters · filed 2022-08-04 | -$59.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$15.00K 10-Q · filed 2022-05-05 | -$30.00K derived: sum of 2 quarters · filed 2022-05-05 | -$44.00K derived: sum of 3 quarters · filed 2022-05-05 | -$57.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$29.00K derived: sum of 2 quarters · filed 2022-03-09 | -$42.00K derived: sum of 3 quarters · filed 2022-03-09 | -$57.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$27.00K derived: sum of 2 quarters · filed 2021-11-04 | -$42.00K 10-Q · filed 2021-11-04 | -$57.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$28.00K 10-Q · filed 2021-08-05 | -$43.00K derived: sum of 3 quarters · filed 2021-08-05 | -$56.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$15.00K 10-Q · filed 2021-05-06 | -$30.00K derived: sum of 2 quarters · filed 2021-05-06 | -$43.00K derived: sum of 3 quarters · filed 2021-05-06 | -$56.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$28.00K derived: sum of 2 quarters · filed 2021-03-25 | -$41.00K derived: sum of 3 quarters · filed 2021-03-25 | -$53.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$26.00K derived: sum of 2 quarters · filed 2020-11-10 | -$38.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$25.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$12.00K 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |